Carlsmed Names Richard Heppenstall CFO, Reaffirms Annual Revenue Outlook

Carlsmed, Inc. (CARL) appointed Richard Heppenstall as chief financial officer, effective September 28, 2026, succeeding Leo Greenstein, who is departing to pursue other professional opportunities. The medical technology company also reaffirmed its full-year revenue guidance. Heppenstall assumes the CFO role immediately, taking over financial leadership as the company maintains its previously issued annual revenue outlook. Carlsmed did not disclose specific guidance figures or the terms of Greenstein's departure in the announcement. The executive change places a new finance chief atop the company's reporting and capital strategy functions. Carlsmed is a medical technology company.